Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 8/20 | 0.56 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.55 |
| ▸ | GBA1 | P04062 | 6/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18757279 | 1.00 | CYP19A1 (0.56) | CYP19A1HRH4HRH3GBA1EPHX2 | |
| SCHEMBL10079147 | 1.00 | CYP19A1 (0.56) | CYP19A1HRH4HRH3GBA1EPHX2 | |
| SCHEMBL10299507 | 0.98 | HRH4 (0.54) | CYP19A1HRH4HRH3GBA1EPHX2 | |
| SCHEMBL10312474 | 0.94 | HRH4 (0.49) | CYP19A1HRH4HRH3GBA1EPHX2 | |
| SCHEMBL10079149 | 0.93 | HRH4 (0.57) | CYP19A1HRH4HRH3GBA1EPHX2 | |
| SCHEMBL18489327 | 0.93 | HRH4 (0.57) | CYP19A1HRH4HRH3GBA1EPHX2 | |
| SCHEMBL18489275 | 0.91 | HRH4 (0.56) | CYP19A1HRH4HRH3GBA1EPHX2 | |
| SCHEMBL19479091 | 0.91 | HRH4 (0.56) | CYP19A1HRH4HRH3GBA1EPHX2 | |
| SCHEMBL22762136 | 0.91 | HRH4 (0.56) | CYP19A1HRH4HRH3GBA1EPHX2 | |
| SCHEMBL18494157 | 0.91 | HRH4 (0.56) | CYP19A1HRH4HRH3GBA1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200384085-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2020-12-10 | — | — | US | disclosed |
| US-10543255-B2 | Peptides comprising non-natural amino acids and methods of making and using the same | LONGEVITY BIOTECH, INC. (US) | 2020-01-28 | — | — | US | disclosed |
| US-10308699-B2 | Peptidomimetic macrocycles | AILERON THERAPEUTICS, INC. (US) | 2019-06-04 | — | — | US | disclosed |
| US-10022422-B2 | Peptidomimetic macrocycles | Alleron Therapeutics, Inc. (US) | 2018-07-17 | — | — | US | disclosed |
| US-20180193423-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2018-07-12 | — | — | US | disclosed |
| US-9957296-B2 | Triazole macrocycle systems | AILERON THERAPEUTICS, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| US-20170360881-A1 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF | AILERON THERAPEUTICS, INC. | 2017-12-21 | — | — | US | disclosed |
| US-9789164-B2 | Peptides comprising non-natural amino acids and methods of making and using the same | LONGEVITY BIOTECH, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| US-20170226177-A1 | PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180193423-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | APLNR, SCTR, GIPR | CYP19A1 3820/4885HRH4 1253/4885HRH3 1725/4885 |
| US-20200384085-A1 | PEPTIDES COMPRISING NON-NATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | APLNR, SCTR, GIPR | CYP19A1 3820/4885HRH4 1253/4885HRH3 1725/4885 |
| US-10308699-B2 | Peptidomimetic macrocycles | GHRHR, GHSR, GHITM | CYP19A1 154/4885HRH4 1954/4885HRH3 2166/4885 |
| US-20170226177-A1 | PEPTIDOMIMETIC MACROCYCLES | GHRHR, GHSR, GHITM | CYP19A1 154/4885HRH4 1954/4885HRH3 2166/4885 |
| US-10543255-B2 | Peptides comprising non-natural amino acids and methods of making and using the same | APLNR, SCTR, GIPR | CYP19A1 3820/4885HRH4 1253/4885HRH3 1725/4885 |
| US-20170360881-A1 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF | VIP, FLT3, HAVCR2 | CYP19A1 3048/4885HRH4 2338/4885HRH3 1911/4885 |
| US-10022422-B2 | Peptidomimetic macrocycles | HAVCR2, ZC3HAV1, ZC3HAV1L | CYP19A1 4006/4885HRH4 2819/4885HRH3 2156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.